ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers

Affiliations

¹ The Queen Silvia Childrens Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
² Department of Pediatrics, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
³ Clinique Pédiatrique, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
⁴ Department of Pediatric Endocrinology, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.
⁵ Paediatric Department, Oslo University Hospital, Oslo, Norway.
⁶ Center for Healthcare Delivery Science, Nemours Children's Health, Jacksonville, Florida, USA.
⁷ Department of Paediatrics & Child Health, School of Medicine, College of Health Sciences Makerere University, Kampala, Uganda.
⁸ Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital and School of Health Sciences, University of Newcastle, Newcastle, New South Wales, Australia.
⁹ Yale School of Medicine, New Haven, Connecticut, USA.
¹⁰ Department of Psychiatry and Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
¹¹ SummitStone Health Partners, Fort Collins, Colorado, USA.
¹² Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Frida Sundberg et al. Pediatr Diabetes. 2022 Dec.

. 2022 Dec;23(8):1496-1511.

doi: 10.1111/pedi.13427.

¹ The Queen Silvia Childrens Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
² Department of Pediatrics, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
³ Clinique Pédiatrique, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
⁴ Department of Pediatric Endocrinology, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.
⁵ Paediatric Department, Oslo University Hospital, Oslo, Norway.
⁶ Center for Healthcare Delivery Science, Nemours Children's Health, Jacksonville, Florida, USA.
⁷ Department of Paediatrics & Child Health, School of Medicine, College of Health Sciences Makerere University, Kampala, Uganda.
⁸ Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital and School of Health Sciences, University of Newcastle, Newcastle, New South Wales, Australia.
⁹ Yale School of Medicine, New Haven, Connecticut, USA.
¹⁰ Department of Psychiatry and Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
¹¹ SummitStone Health Partners, Fort Collins, Colorado, USA.
¹² Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.

No abstract available

References

1. Rawshani A, Sattar N, Franzen S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register‐based cohort study. Lancet. 2018;392(10146):477‐486. - PMC - PubMed
1. Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9‐16. - PMC - PubMed
1. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972‐1982. - PubMed
1. Hanberger L, Samuelsson U, Berterö C, Ludvigsson J. The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2012;96(3):331‐338. - PubMed
1. Van Loocke M, Battelino T, Tittel SR, et al. Lower HbA1c targets are associated with better metabolic control. Eur J Pediatr. 2021;180(5):1513‐1520. - PubMed